1. Home
  2. SOTK vs PYPD Comparison

SOTK vs PYPD Comparison

Compare SOTK & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sono-Tek Corporation

SOTK

Sono-Tek Corporation

HOLD

Current Price

$4.09

Market Cap

68.8M

Sector

Technology

ML Signal

HOLD

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

N/A

Current Price

$4.25

Market Cap

76.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SOTK
PYPD
Founded
1975
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.8M
76.4M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
SOTK
PYPD
Price
$4.09
$4.25
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
N/A
$12.00
AVG Volume (30 Days)
24.0K
46.4K
Earning Date
04-09-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.08
N/A
Revenue
$20,504,381.00
N/A
Revenue This Year
$4.02
N/A
Revenue Next Year
$10.95
N/A
P/E Ratio
$51.19
N/A
Revenue Growth
4.08
N/A
52 Week Low
$3.23
$2.30
52 Week High
$5.15
$5.12

Technical Indicators

Market Signals
Indicator
SOTK
PYPD
Relative Strength Index (RSI) 46.60 46.85
Support Level $4.05 $4.26
Resistance Level $4.18 $5.05
Average True Range (ATR) 0.18 0.25
MACD -0.01 -0.05
Stochastic Oscillator 44.04 37.14

Price Performance

Historical Comparison
SOTK
PYPD

About SOTK Sono-Tek Corporation

Sono-Tek Corp design and manufacture of ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial and emerging research & development/other markets. The company design and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with strong applications engineering knowledge, to assist its customers in achieving their desired coating solutions.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: